175 results
S-8
EX-4.4
x1sehhf98
22 Feb 24
Registration of securities for employees
5:50pm
S-8
EX-4.5
1ebxh3bblv9uks0ho
22 Feb 24
Registration of securities for employees
5:50pm
8-K
EX-99.2
bxip2nz
30 Nov 23
AbbVie to Acquire ImmunoGen, including its Flagship Cancer Therapy ELAHERE® (mirvetuximab soravtansine-gynx), Expanding Solid Tumor Portfolio
8:47am
8-K
EX-99.1
7uvhk u4f55wr9
30 Nov 23
AbbVie to Acquire ImmunoGen, including its Flagship Cancer Therapy ELAHERE® (mirvetuximab soravtansine-gynx), Expanding Solid Tumor Portfolio
8:47am
11-K
1qpdicm d8
28 Jun 23
Annual report of employee stock purchases
5:00pm